Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Development of TZP-101 extended to include patients with gastroparesis

Sep. 26, 2006

AT-1001 studied in phase II trial for celiac disease

Sep. 26, 2006

Itax development discontinued in functional dyspepsia and diabetic gastropathy

Sep. 26, 2006

Baraclude launched in Japan

Sep. 26, 2006

Avidia advances novel IL-6 inhibitor to phase I for Crohn's disease

Sep. 22, 2006

Progenics and Wyeth begin pivotal trials with POI drug candidate

Sep. 22, 2006

Sapphire license ghrelin mimetic from Novo Nordisk

Sep. 22, 2006

Recent patents disclose novel treatment strategies for HCV infection

Sep. 21, 2006

Idenix receives first approval for novel CHB treatment

Sep. 21, 2006

Snapshots on novel hepatitis C virus polymerase inhibitors presented at the ACS meeting

Sep. 18, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...